Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Perindopril erbumine 4mg
You Searched
Perigard 4mg Tablet
₹130
Our Recommendation
Perindprim 4mg Tablet 10s
946+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
In Hypertension (high blood pressure) Perigard 4mg Tablet reduces stress on the heart and relaxes the blood vessels. This widens the blood vessels and makes it easier for the heart to pump blood around your body, thereby lowering your blood pressure. Controlled blood pressure reduces the risk of having a heart attack, stroke, or kidney problems. The medicine must be taken regularly, as prescribed, to be effective. You do not usually feel immediate benefit from taking this medicine, however, it helps you maintain your blood pressure in the long term. In Prevention of heart attack and stroke Perigard 4mg Tablet lowers your blood pressure. As a result, it reduces the chance of damage to the small blood vessels in your heart and kidneys. This reduces the risk of getting a heart attack and kidney problems. It also helps in slowing down the rate at which they get worse if you already have problems. This medicine must be taken regularly to be effective. In Heart failure Perigard 4mg Tablet makes it easier for your heart to pump blood around your body so the heart has to do less work. This can improve your heart function and reduce the symptoms of heart failure. It will help improve your quality of life and enable you to go about your daily activities more efficiently. The medicine must be taken regularly and as long as the doctor has prescribed it to be effective.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Perigard 4mg Tablet is to be taken empty stomach.
Perigard 4mg Tablet is an angiotensin converting enzyme (ACE) inhibitor. It works by reducing stress on the heart and relaxing blood vessel so that blood flows more smoothly and the heart can pump blood more efficiently.
Unsafe: Avoid consuming alcohol with Perigard 4mg Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Perigard 4mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Safe when prescribed by an expert: Perigard 4mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not Safe: Perigard 4mg Tablet may cause side effects which could affect your ability to drive. Perigard 4mg Tablet usually does not affect alertness but dizziness or weakness due to low blood pressure may occur in some patients. This may affect your driving ability.
Caution Advised: Perigard 4mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Perigard 4mg Tablet may be needed. Doctor consultation is advised. Caution should be advised in patients with renal impairment.
Caution Advised: Perigard 4mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Perigard 4mg Tablet may be needed. Doctor consultation is advised. Inform your doctor if you develop any signs and symptoms of jaundice while taking this medicine.
If you forget a dose of Perigard 4mg Tablet , simply continue with your regular schedule and do not take a double dose.
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai ‚ 400 026.
Pfeffer MA, Opie LH. Inhibitors of the Renin-Angiotensin-Aldosterone System. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 143
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1091-92
Perindopril erbumin (20 Mar. 2019)
Central Drugs Standard Control Organisation. Perindopril erbumine (05 Aug. 2023)
Simpson D, Noble S, Goa KL. Perindopril: in congestive heart failure. Drugs. 2002;62(9):1367-77; discussion 1378-9 (05 Aug. 2023)
Perindopril erbumine (01 Mar. 2025)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.